Nantahala Capital Management, LLC Ocuphire Pharma, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCUP
# of Institutions
52Shares Held
14.6MCall Options Held
13.7KPut Options Held
1K-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.18% of portfolio
-
Opaleye Management Inc. Boston, MA1.18MShares$1.15 Million0.32% of portfolio
-
Bios Capital Management, LP Fort Worth, TX995KShares$975,3441.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL810KShares$793,8780.84% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...